Recurrent Hematologic Malignancy

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB12001	Abemaciclib	1	Terminated	1
DB05812	Abiraterone	1	Terminated	1
DB00316	Acetaminophen	1	Active Not Recruiting	1
DB08916	Afatinib	1	Terminated	1
DB00062	Albumin human	1	Terminated	1
DB09495	Avobenzone	1	Terminated	1
DB00112	Bevacizumab	1	Terminated	1
DB01128	Bicalutamide	1	Terminated	1
DB00188	Bortezomib	1	Terminated	1
DB16741	Bortezomib D-mannitol	1	Terminated	1
DB06772	Cabazitaxel	1	Terminated	1
DB08875	Cabozantinib	1	Terminated	1
DB01101	Capecitabine	1	Terminated	1
DB00958	Carboplatin	1	Terminated	1
DB00482	Celecoxib	1	Terminated	1
DB05239	Cobimetinib	1	Terminated	1
DB12483	Copanlisib	1	Terminated	1
DB08912	Dabrafenib	1	Terminated	1
DB11963	Dacomitinib	1	Terminated	1
DB12941	Darolutamide	1	Terminated	1
DB01254	Dasatinib	1	Terminated	1
DB00694	Daunorubicin	1	Terminated	1
DB01234	Dexamethasone	1	Active Not Recruiting	1
DB01075	Diphenhydramine	1	Active Not Recruiting	1
DB00997	Doxorubicin	1	Terminated	1
DB11714	Durvalumab	1	Terminated	1
DB13874	Enasidenib	1	Terminated	1
DB11986	Entrectinib	1	Terminated	1
DB08899	Enzalutamide	1	Terminated	1
DB00530	Erlotinib	1	Terminated	1
DB01590	Everolimus	1	Terminated	1
DB15223	Flotetuzumab	1	Active Not Recruiting	1
DB01073	Fludarabine	1	Recruiting	1
DB00544	Fluorouracil	1	Terminated	1
DB01050	Ibuprofen	1	Active Not Recruiting	1
DB09054	Idelalisib	1	Terminated	1
DB00619	Imatinib	1	Terminated	1
DB06186	Ipilimumab	1	Completed	1
DB06186	Ipilimumab	1	Terminated	1
DB09078	Lenvatinib	1	Terminated	1
DB00650	Leucovorin	1	Terminated	1
DB12130	Lorlatinib	1	Terminated	1
DB00678	Losartan	1	Terminated	1
DB01042	Melphalan	1	Recruiting	1
DB00688	Mycophenolate mofetil	1	Recruiting	1
DB11828	Neratinib	1	Terminated	1
DB09035	Nivolumab	1	Completed	1
DB09035	Nivolumab	1	Terminated	1
DB09496	Octinoxate	1	Terminated	1
DB09074	Olaparib	1	Terminated	1
DB00526	Oxaliplatin	1	Terminated	1
DB01229	Paclitaxel	1	Terminated	1
DB09073	Palbociclib	1	Terminated	1
DB06603	Panobinostat	1	Terminated	1
DB09037	Pembrolizumab	1	Terminated	1
DB06366	Pertuzumab	1	Terminated	1
DB08901	Ponatinib	1	Terminated	1
DB00863	Ranitidine	1	Active Not Recruiting	1
DB08896	Regorafenib	1	Terminated	1
DB08877	Ruxolitinib	1	Terminated	1
DB00877	Sirolimus	1	Terminated	1
DB00398	Sorafenib	1	Terminated	1
DB01268	Sunitinib	1	Terminated	1
DB00864	Tacrolimus	1	Recruiting	1
DB08911	Trametinib	1	Terminated	1
DB05773	Trastuzumab emtansine	1	Terminated	1
DB00755	Tretinoin	1	Terminated	1
DB08881	Vemurafenib	1	Terminated	1
DB11581	Venetoclax	1	Terminated	1
DB08828	Vismodegib	1	Terminated	1
DB02546	Vorinostat	1	Terminated	1
DB15223	Flotetuzumab	2	Withdrawn	1